IL-1β up-regulates PD-L1 via STAT3-dependent and independent mechanism in esophageal squamous cell carcinoma

被引:0
|
作者
Zheng, S. [1 ]
Liu, Q. [1 ]
Ma, R. [1 ,2 ]
机构
[1] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Urumqi, Xinjiang Uygur, Peoples R China
[2] Xinjiang Med Univ, Urumqi, Peoples R China
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P3054
引用
收藏
页码:1576 / 1576
页数:1
相关论文
共 50 条
  • [21] The Concentration of PD-L1 in the Peripheral Blood is a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
    Akutsu, Y.
    Hanari, N.
    Murakami, K.
    Kano, M.
    Usui, A.
    Suioto, H.
    Takahashi, M.
    Matsumoto, Y.
    Otsuka, R.
    Matsubara, H.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S154 - S154
  • [22] EBV up-regulates PD-L1 on the surface of primary monocytes by increasing ROS and activating TLR signaling and STAT3
    Gilardini Montani, Maria Saveria
    Santarelli, Roberta
    Falcinelli, Luca
    Gonnella, Roberta
    Granato, Marisa
    Di Renzo, Livia
    Cuomo, Laura
    Vitillo, Marina
    Faggioni, Alberto
    Cirone, Mara
    JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 104 (04) : 821 - 832
  • [23] Interleukin-17A up-regulates keratin 17 expression in HaCaT cells through STAT1 and STAT3-dependent mechanisms
    Wang, Gang
    Shi, Xiaowei
    Liu, Yufeng
    JOURNAL OF DERMATOLOGY, 2010, 37 : 119 - 119
  • [24] Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma
    Steen, Sonja
    Semmelmayer, Karl
    Flechtenmacher, Christa
    Hoffmann, Juergen
    Freier, Kolja
    Horn, Dominik
    Hess, Jochen
    Freudlsperger, Christian
    Moratin, Julius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [25] PD-1 and PD-L1 staining patterns in cervical squamous cell carcinoma
    Hodeib, M.
    Lester, J.
    Laury, A.
    Cass, I.
    Rimel, B. J.
    Li, A. J.
    Karlan, B. Y.
    Walsh, C. S.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 210 - 210
  • [26] The analysis of T cell subset and the expression of PD-L1, HLA in esophageal squamous cell carcinoma.
    Sudo, Tomoya
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Concordance among the three commercially available PD-L1 assays for esophageal squamous cell carcinoma
    Wang, Lizhen
    Guo, Jhe-Cyuan
    Chuang, Chien Huai
    Cao, Grace
    Huang, Stacey
    Liu, Jia
    Guo, Tony
    Wu, Tsung-Che
    Li, Shuang
    Lin, Jing
    King, Hsi-Yu
    Cai, Jun
    Yang, Wenjun
    Liu, Qingyuan
    Allen, Simon
    Wang, Yifan
    Zhang, Jingyu
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
    Wang, Xinran
    He, Jiankun
    Li, Jinze
    Wu, Chun
    Yue, Meng
    Niu, Shuyao
    Jia, Ying
    Jia, Zhanli
    Cai, Lijing
    Liu, Yueping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [29] PD-L1 Immunohistochemical Comparability Multi-Institutional Study in Esophageal Squamous Cell Carcinoma
    Liu, Yueping
    Wang, Xinran
    He, Jiankun
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 486 - 487
  • [30] PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
    Wang, Qiao
    Feng, Fan
    Wang, Fei
    Liu, Zhen
    Liu, Shushang
    Xu, Guanghui
    Zheng, Gaozan
    Guo, Man
    Lian, Xiao
    Zhang, Hongwei
    JOURNAL OF CANCER, 2018, 9 (12): : 2224 - 2231